Dr Jagdish Kumar Jaiswal

BPharm, MPharm, PhD


  • B. Pharm - Institute of Technology, Banaras Hindu University (India)
  • M. Pharm (Pharmaceutics) - Jadavpur University (India)
  • PhD (Pharmacology) - All India Institute of Medical Sciences (India)
  • Visiting DAAD Fellow in the laboratories of Prof. Jorg Kreuter at Frankfurt Biocentre, Johann Wolfgang Goethe University, Germany
  • Research Associate (Drug Discovery- Pharmacology)-  Torrent Research Centre, India
  • Post doctoral research fellow - Auckland Cancer Society Research Centre (2005-2007)

Research interests

Current Projects

Small molecules perforin inhibitor (Wellcome Trust, UK)

Past projects

  • Clinical Phase I candidate PR-610. Pre-clinical pharmacokinetic studies (PIs- Drs Adam Patterson and Jeff Smaiil)
  • Clinical Phase II/III candidate PR-104. Formulation stability and rat toxicity study (Principal Investigator - Prof. Bill Wilson)
  • Clinical development candidate CEN-209 (SN30000). preclinical ADME studies (Principal Investigator - Prof. Bill Wilson)
  • NitroCBI analogs. Preclinical  ADME studies (Principal Investigators Drs. Frederik Pruijn and Moana Tercel)

Research | Current

  • ADME/Tox of anti cancer drugs in pre-clinical development
  • LC-MS/MS method development

Postgraduate supervision

Small animal pharmacokinetic studies



Pre clinical DMPK studies (small animals)

Bio-analysis (LC-MS/MS, LC-MS, Ion trap, HPLC)

Areas of expertise

Preclinical drug development of small molecules

Measurement of drug, metabolites in biological matrix (serum, plasma, saliva etc) by LC-MS/MS, HPLC.

Selected publications and creative works (Research Outputs)

As of 29 October 2020 there will be no automatic updating of 'selected publications and creative works' from Research Outputs. Please continue to keep your Research Outputs profile up to date.

Contact details

Primary office location

M&HS BUILDING 504 - Bldg 504
Level 0, Room 001
New Zealand